RIO DE JANEIRO, BRAZIL - The Brazilian Health Regulatory Agency (ANVISA) on Wednesday, February 16, received a request from U.S. pharmaceutical company Pfizer for the emergency use of Paxlovid, a drug to treat Covid-19, the regulator reported.
Paxlovid is currently in use in the United States, China, Canada, Japan, and European Union countries. The data presented by the laboratory that the drug can reduce hospitalization and deaths by up to 89% when administered early in the infection will now be reviewed by ANVISA.
The deadline for the assessment of the request will be 30 days, and within 24 hours . . .